1cP-LSD
Appearance
(Redirected from 1CP-LSD)
Clinical data | |
---|---|
Other names | 1cP, acid, LSD, Lucy |
Dependence liability | Low |
Addiction liability | None |
Routes of administration | By mouth, under the tongue |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Onset of action | 30 - 60 minutes |
Duration of action | 8 - 24 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C24H29N3O2 |
Molar mass | 391.515 g·mol−1 |
3D model (JSmol) | |
| |
|
1cP-LSD (N1-(cyclopropylmethanoyl)-lysergic acid diethylamide) is an acylated derivative of lysergic acid diethylamide (LSD), which has been sold as a designer drug. [1][2] It was first synthesized as a legal-LSD alternative by Lizard Labs, a Netherlands based research chemical laboratory.[3] In tests on mice it was found to be an active psychedelic with similar potency to 1P-LSD.[4]
Legal status
[edit]Sweden's public health agency suggested classifying 1cP-LSD as a dangerous substance on 18 December 2019 and later classified it as such on 22 April 2021.[5][6]
See also
[edit]- Lysergic acid diethylamide (LSD)
- 1B-LSD
- 1DD-LSD
- 1P-LSD
- 1V-LSD
- ALD-52
- 1cP-AL-LAD
- AL-LAD
- ETH-LAD
- 1P-ETH-LAD
- PRO-LAD
- LSM-775
- LSZ
- O-Acetylpsilocin (4-AcO-DMT)
References
[edit]- ^ Tanaka R, Kawamura M, Hakamatsuka T, Kikura-Hanajiri R (2020). "[Identification of LSD Derivatives, 1cP-LSD, MIPLA and 1B-LSD in Illegal Products as Paper Sheet]". Yakugaku Zasshi. 140 (11): 1405–1413. doi:10.1248/yakushi.20-00124. PMID 33132277.
- ^ Vincenti F, Gregori A, Flammini M, Di Rosa F, Salomone A (July 2021). "Seizures of New Psychoactive Substances on the Italian territory during the COVID-19 pandemic". Forensic Science International. 326: 110904. doi:10.1016/j.forsciint.2021.110904. PMC 8411784. PMID 34371393.
- ^ spotlight (2018-07-25). "About Us - Lizard Labs". lizardlabs.nl. Retrieved 2024-09-13.
- ^ Brandt SD, Kavanagh PV, Westphal F, Stratford A, Odland AU, Klein AK, et al. (June 2020). "Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD)". Drug Testing and Analysis. 12 (6): 812–826. doi:10.1002/dta.2789. PMC 9191646. PMID 32180350.
- ^ "Förordning (1999:58) om förbud mot vissa hälsofarliga varor".
- ^ "Tjugotre ämnen föreslås klassas som narkotika eller hälsofarlig vara" [Twenty-three substances are proposed to be classified as drugs or dangerous goods] (in Swedish). Folkhälsomyndigheten. December 18, 2019. Archived from the original on November 24, 2022. Retrieved May 28, 2020.